Publication:
Clinical phenotype clustering in cardiovascular risk patients for the identification of responsive metabotypes after red wine polyphenol intake.

dc.contributor.authorVázquez-Fresno, Rosa
dc.contributor.authorLlorach, Rafael
dc.contributor.authorPerera, Alexandre
dc.contributor.authorMandal, Rupasri
dc.contributor.authorFeliz, Miguel
dc.contributor.authorTinahones, Francisco J
dc.contributor.authorWishart, David S
dc.contributor.authorAndres-Lacueva, Cristina
dc.date.accessioned2023-01-25T08:30:59Z
dc.date.available2023-01-25T08:30:59Z
dc.date.issued2015-10-26
dc.description.abstractThis study aims to evaluate the robustness of clinical and metabolic phenotyping through, for the first time, the identification of differential responsiveness to dietary strategies in the improvement of cardiometabolic risk conditions. Clinical phenotyping of 57 volunteers with cardiovascular risk factors was achieved using k-means cluster analysis based on 69 biochemical and anthropometric parameters. Cluster validation based on Dunn and Figure of Merit analysis for internal coherence and external homogeneity were employed. k-Means produced four clusters with particular clinical profiles. Differences on urine metabolomic profiles among clinical phenotypes were explored and validated by multivariate orthogonal signal correction partial least-squares discriminant analysis (OSC-PLS-DA) models. OSC-PLS-DA of (1)H-NMR data revealed that model comparing "obese and diabetic cluster" (OD-c) against "healthier cluster" (H-c) showed the best predictability and robustness in terms of explaining the pairwise differences between clusters. Considering these two clusters, distinct groups of metabolites were observed following an intervention with wine polyphenol intake (WPI; 733 equivalents of gallic acid/day) per 28days. Glucose was significantly linked to OD-c metabotype (P
dc.identifier.doi10.1016/j.jnutbio.2015.10.002
dc.identifier.essn1873-4847
dc.identifier.pmid26878788
dc.identifier.unpaywallURLhttps://upcommons.upc.edu/bitstream/2117/85014/1/RMN_Wine%20draft_1a.pdf
dc.identifier.urihttp://hdl.handle.net/10668/9837
dc.journal.titleThe Journal of nutritional biochemistry
dc.journal.titleabbreviationJ Nutr Biochem
dc.language.isoen
dc.organizationInstituto de Investigación Biomédica de Málaga-IBIMA
dc.organizationHospital Universitario Virgen de la Victoria
dc.page.number114-20
dc.pubmedtypeJournal Article
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject4-Hydroxyphenylacetate
dc.subjectCardiovascular disease
dc.subjectGut microbiota
dc.subjectMetabolic phenotype
dc.subjectMetabolomics
dc.subjectMetabotype
dc.subjectNMR
dc.subjectWine polyphenols
dc.subject.meshCardiovascular Diseases
dc.subject.meshCluster Analysis
dc.subject.meshHumans
dc.subject.meshMetabolomics
dc.subject.meshPhenotype
dc.subject.meshPolyphenols
dc.subject.meshProton Magnetic Resonance Spectroscopy
dc.subject.meshWine
dc.titleClinical phenotype clustering in cardiovascular risk patients for the identification of responsive metabotypes after red wine polyphenol intake.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number28
dspace.entity.typePublication

Files